Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:


FP7-HEALTH (1803)
FP7-KBBE (40)
FP7-NMP (56)
FP6-INCO (23)

Content type

Project (405)
Result in Brief (1440)
Report Summary (431)


Albania (3)
Algeria (1)
Argentina (5)
Australia (7)
Austria (112)
Bangladesh (2)
Belarus (1)
Belgium (210)
Benin (3)
Bolivia (2)
Bosnia and Herzegovina (1)
Botswana (1)
Brazil (4)
Bulgaria (9)
Burkina Faso (6)
Cambodia (1)
Cameroon (3)
Canada (7)
Chile (4)
China (5)
Colombia (2)
Croatia (6)
Cyprus (5)
Czech Republic (18)
Côte d’Ivoire (1)
Democratic Republic of the Congo (4)
Denmark (75)
Ecuador (2)
Egypt (5)
Estonia (13)
Ethiopia (1)
Finland (82)
Former Yugoslav Republic of Macedonia (1)
France (460)
Gabon (1)
Georgia (1)
Germany (546)
Ghana (13)
Greece (37)
Guinea-Bissau (1)
Hong Kong (2)
Hungary (35)
Iceland (2)
India (17)
Indonesia (1)
Ireland (87)
Israel (84)
Italy (307)
Japan (2)
Kenya (7)
Latvia (7)
Lebanon (1)
Lithuania (9)
Luxembourg (3)
Malawi (5)
Malaysia (1)
Mali (6)
Mexico (1)
Montenegro (1)
Morocco (3)
Mozambique (2)
Nepal (3)
Netherlands (290)
Nigeria (4)
Norway (52)
Paraguay (1)
Peru (3)
Philippines (1)
Poland (35)
Portugal (35)
Romania (15)
Russia (8)
Senegal (4)
Serbia (1)
Singapore (1)
Slovakia (10)
Slovenia (10)
South Africa (11)
South Korea (3)
Spain (260)
Sudan (3)
Sweden (223)
Switzerland (152)
Taiwan (1)
Tanzania (8)
Thailand (2)
The Gambia (1)
Togo (2)
Tunisia (6)
Turkey (10)
Uganda (9)
United Arab Emirates (1)
United Kingdom (490)
United States (33)
Uruguay (3)
Venezuela (3)
Vietnam (4)
Zambia (1)
Zimbabwe (2)

Advanced search

Search projects and results

Results 1 - 10 of 2276
12 3 4 5 6 7 8 9 10 > >| 
EUROmediCAT: Safety of Medication use in Pregnancy in Relation to Risk of Congenital Malformations
ID: 260598
Start date: 2011-03-01, End date: 2015-02-28
A variety of complementary approaches are needed to evaluate safety of medicine use in pregnancy. To evaluate safety in relation to teratogenicity (capacity to cause malformations), population-based congenital anomaly registers, which are already networked across Europe (EURO...
Programme: FP7-HEALTH
Record Number: 98223
Last updated on: 2017-05-26
Fatty liver: Inhibition of Progression
ID: 241762
Start date: 2010-01-01, End date: 2013-06-30
Non-alcoholic fatty liver disease (NAFLD) has become one of the top concerns for the practising hepatogastroenterologist due to the obesity epidemic and its potential to progress to advanced liver disease which significantly impacts on overall and liver-related mortality. The...
Programme: FP7-HEALTH
Record Number: 93615
Last updated on: 2017-05-25
Biology and control of vector-borne infections in Europe
ID: 261504
Start date: 2011-01-01, End date: 2015-06-30
To address the call for proposals 'Biology and control of vector-borne infections in Europe' launched by the European Commission, we want to investigate the biological, ecological and epidemiological components of vector-borne diseases (VBD) introduction, emergence and spread...
Programme: FP7-HEALTH
Record Number: 97622
Last updated on: 2017-05-26
European Network for Cell Imaging and Tracking Expertise
ID: 201842
Start date: 2008-06-01, End date: 2012-11-30
Cell therapy can be defined as the transplantation of living cells for the treatment of medical disorders. Three different principles underlie the increasing interest in cell therapy. 1. Transplanted cells used as an “active drug” 2. Transplanted cells used to replace damaged...
Programme: FP7-HEALTH
Record Number: 88226
Last updated on: 2017-05-29
BIOactive highly porous and injectable Scaffolds controlling stem cell recruitment, proliferation and differentiation and enabling angiogenesis for Cardiovascular ENgineered Tissues
ID: 214539
Start date: 2009-01-01, End date: 2013-12-31
Congenital and acquired diseases of the heart are the leading causes of morbidity and mortality in the world today; 7.2 million people die each year due to coronary heart disease, being the first cause of mortality in population above 60 years old, and the second cause after ...
Programme: FP7-NMP
Record Number: 90453
Last updated on: 2017-05-25
Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis
ID: 258677
Start date: 2011-01-01, End date: 2014-06-30
Lung cancer (LC) is still the most lethal type of cancer worldwide. The extremely poor prognosis for LC patients is partly due to the lack of effective therapies. At present, most patients with pulmonary carcinomas are treated with chemotherapy. This essentially consists of c...
Programme: FP7-HEALTH
Record Number: 97659
Last updated on: 2017-05-26
Modelling and predicting sensitivity to targeted therapies in colorectal cancers
ID: 259015
Start date: 2011-01-01, End date: 2014-12-31
Effective and long term treatment of cancer is now in sight, but will ultimately require an increasingly ‘personalised’ approach where the ‘right’ combination of drugs will be administered to the ‘right’ patients, based on a detailed understanding of their genetic background ...
Programme: FP7-HEALTH
Record Number: 98370
Last updated on: 2017-05-29
A comprehensive dissection of pneumococcal-host interactions
ID: 222983
Start date: 2009-03-01, End date: 2012-08-31
This project is a fundamental, comprehensive study of the host-pathogen interactions during infection with Streptococcus pneumoniae. The expectation is that the basic knowledge gained from this work will give new targets for vaccination, diagnosis and treatment. In PNEUMOPATH...
Programme: FP7-HEALTH
Record Number: 91044
Last updated on: 2017-05-25
PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
Mechanisms of the Development of ALLergy
ID: 261357
Start date: 2010-12-01, End date: 2015-05-31
Causes explaining the epidemic of IgE-associated (allergic) diseases are unclear. MeDALL (Mechanisms of the Development of Allergy) aims at generating novel knowledge on mechanisms of allergy initiation, in particular in childhood. To understand how a complex network of genet...
Programme: FP7-HEALTH
Record Number: 96850
Last updated on: 2017-05-26
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-03-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top